Hester Biosciences Limited
NSE:HESTERBIO.NS
2,673.15 (INR) • At close November 8, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Hester Biosciences Limited |
Symbool | HESTERBIO.NS |
Munteenheid | INR |
Prijs | 2,673.15 |
Beurswaarde | 22,740,139,541 |
Dividendpercentage | 0.45% |
52-weken bereik | 1,292.85 - 3,379 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Rajiv Dinesh Gandhi B.Com |
Website | https://www.hester.in |
An error occurred while fetching data.
Over Hester Biosciences Limited
Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates in two segments, Poultry Healthcare and Animal Healthcare. The company provides poultry vaccines for diseases, such as newcastle disease, infectious bronchitis, infectious bursal disease, fowl pox, egg drop syndrome, reo, marek's
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (INR)
Cijfers zijn in miljoenen (INR)